Company: BK-PK
Filing Date: 2025-06-04
Form Type: 424B2
Source: 0001193125-25-134936
Chunk: 4

Company: Bank of New York Mellon Corp
Filing Date: 2025-06-04
Form: 424B2
Chunk 4
---
 |
| BNY Mellon Capital Markets, LLC       |     | $                          |  60,000,000 |
| Commonwealth Bank of Australia        |     | $                          |  11,250,000 |
| Credit Agricole Securities (USA) Inc. |     | $                          |  11,250,000 |
| Intesa Sanpaolo IMI Securities Corp.  |     | $                          |  11,250,000 |
| Scotia Capital (USA) Inc.             |     | $                          |  11,250,000 |
| Cabrera Capital Markets LLC           |     | $                          |   7,500,000 |
| CastleOak Securities, L.P.            |     | $                          |   7,500,000 |
| CAVU Securities LLC                   |     | $                          |   7,500,000 |
| MFR Securities, Inc.                  |     | $                          |   7,500,000 |
| Security Capital Brokerage, Inc.      |     | $                          |   7,500,000 |
| Tigress Financial Partners LLC        |     | $                          |   7,500,000 |
| Total:                                |     | $                          | 750,000,000 |

The Agents expect to deliver the Notes in book-entry form only through the facilities of The Depository Trust Company against payment in New York, New York on or about the fifth business day following the date of this pricing supplement, or “T+5”. Trades of securities in the secondary market generally are required to settle in one business day, referred to as “T+1”, unless the parties to a trade agree otherwise. Accordingly, by virtue of the fact that the initial delivery of the Notes will not be made on a T+1 basis, investors who wish to trade the Notes more than one business day before the Original Issue Date will be required to specify an alternative settlement cycle at the time of any such trade to prevent a failed settlement. The prospectus, prospectus supplement and this pricing supplement may be used by the Company, BNY Mellon Capital Markets, LLC and any other affiliate controlled by the Company in connection with offers and sales relating to the initial sales of securities and any market-making transaction involving the securities after the initial sale. These transactions may be executed at negotiated prices that are related to market prices at the time of purchase or sale, or at other prices. The Company and its affiliates may act as principal or agent in